Evidence map›Paper›PMID 26229391›Full record

ReviewWorld journal of gastroenterology2015

Gastrointestinal cancers in the era of theranostics: Updates and future perspectives.

Marwan Ghosn, Hampig Raphael Kourie, Samer Tabchi

Abstract readEditorialReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Mitochondrial nanotargeting in malignancies (Review).Experimental and therapeutic medicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marwan GhosnMarwan Ghosn, Hampig Raphael Kourie, Samer Tabchi, Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
Hampig Raphael KourieMarwan Ghosn, Hampig Raphael Kourie, Samer Tabchi, Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
Samer TabchiMarwan Ghosn, Hampig Raphael Kourie, Samer Tabchi, Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Theranostics are one of the practical aspects of personalized medicine. This concept was designed to describe a material combining diagnosis, treatment and follow up of a disease. It evolved and included molecular targeting and nanotechnologies that incorporate both diagnosis and therapeutics. In this editorial, we are presenting briefly the concept and evolution of theranostics, highlighting many applications of theranostics in daily practice and discussing future perspectives and aspects of this model in gastro-intestincal cancers.

Indexed as

Theranostic NanomedicineBiomarkers, TumorDiffusion of InnovationForecastingGastrointestinal NeoplasmsGenetic Predisposition to DiseaseHumansMolecular Diagnostic TechniquesMolecular Targeted TherapyPhenotypePredictive Value of TestsTreatment OutcomeBiomarkers, TumorGastrointestinal cancerMolecular targetingNanoparticlesNanotheranosticsTheranostics

Identifiers

PMID26229391
PMCPMC4515830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.